(Q37525969)
Statements
Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease (English)
Bin Zhou
Kenichi Yoshimura
Masanori Fukushima
1 January 2009
scientific article published on January 2009